Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae

Clinical trial NCT02420366 · COMPLETED

Trial details

NCT number: NCT02420366
Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
Status: COMPLETED
Study type: OBSERVATIONAL

Urinary Tract Infection, Complicated Acute Pyelonephritis Hospital Acquired Bacterial Pneumonia Ventilator-associated Bacterial Pneumonia Bacteremia

Start date: 2014-05-01
Primary completion: 2015-01-01
Enrollment: 257

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.